| 发明名称 |
HCV COMBINATION THERAPIES COMPRISING VX-950, PEG-IFN AND RIBAVIRIN |
| 摘要 |
The invention relates to combination therapies for the treatment of hepatitis C virus with telaprevir and pegylated interferon alfa-2a with or without ribavirin. The invention relates to the treatment of Latino and African American patients infected with HCV using the combination therapy. |
| 申请公布号 |
WO2009061395(A3) |
申请公布日期 |
2010.03.18 |
| 申请号 |
WO2008US12460 |
申请日期 |
2008.11.04 |
| 申请人 |
VERTEX PHARMACEUTICALS INCORPORATED;MCNAIR, LINDSAY |
发明人 |
MCNAIR, LINDSAY |
| 分类号 |
A61K31/7056;A61K38/21;A61P31/12 |
主分类号 |
A61K31/7056 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
